Price$389.25+5.06 (+1.32%)
01:30 PM07:45 PM
News · 26 weeks90+183%
2026-02-152026-08-09
Mix2990d
- SEC Filings7(24%)
- Analyst7(24%)
- Other7(24%)
- Insider5(17%)
- Earnings2(7%)
- Leadership1(3%)
Latest news
25 items- PRJames P. Holland to Join Humana as Medicaid PresidentHumana Inc. (NYSE:HUM) today announced that James "J.P." Holland will join the company as senior vice president and President of Medicaid, effective August 17. In this role, Holland will lead the company’s growing Medicaid business, which currently serves more than 1.6 million members in 11 states. Holland will report to Aaron Martin, President of Insurance. "Medicaid is an important part of how we deliver on Humana’s purpose, helping some of the most vulnerable populations access the care and support they need to achieve their best health," said Aaron Martin, President of Insurance at Humana. "J.P. brings deep expertise leading government-sponsored healthcare plans and maintaining strong
- ANALYSTHumana upgraded by Morgan Stanley with a new price targetMorgan Stanley upgraded Humana from Underweight to Equal-Weight and set a new price target of $370.00
- PRHumana Subsidiary iCare Selected for Family Care and Family Care Partnership Contracts Across Southeast WisconsinIndependent Care Health Plan expands service area to all seven counties in Wisconsin's greater southeast region, ensuring continuity for existing members and new access to high-quality long-term care services Independent Care Health Plan (iCare), a Humana subsidiary, has been selected by the Wisconsin Department of Health Services to serve both the Family Care and Family Care Partnership programs in the greater southeast region. This award expands iCare's footprint to all seven counties in the service area and reinforces its leadership in delivering high-quality managed long-term services and supports. The intent to award marks iCare's third consecutive Wisconsin geographic win, with th
- INSIDERDirector Smith Paul John was granted 544 units of Humana Common (SEC Form 4)4 - HUMANA INC (0000049071) (Issuer)
- INSIDERDirector Crawford Frederick John was granted 544 units of Humana Common (SEC Form 4)4 - HUMANA INC (0000049071) (Issuer)
- ANALYSTHumana upgraded by Evercore ISI with a new price targetEvercore ISI upgraded Humana from In-line to Outperform and set a new price target of $480.00
- ANALYSTHumana upgraded by Leerink Partners with a new price targetLeerink Partners upgraded Humana from Market Perform to Outperform and set a new price target of $513.00
- ANALYSTHumana downgraded by Raymond JamesRaymond James downgraded Humana from Outperform to Mkt Perform
- INSIDERNew insider Crawford Frederick John claimed ownership of 21 units of Humana Common (SEC Form 3)3 - HUMANA INC (0000049071) (Issuer)
- INSIDERNew insider Smith Paul John claimed no ownership of stock in the company (SEC Form 3)3 - HUMANA INC (0000049071) (Issuer)
- SECSEC Form 10-Q filed by Humana Inc.10-Q - HUMANA INC (0000049071) (Filer)
- ANALYSTHumana upgraded by BofA Securities with a new price targetBofA Securities upgraded Humana from Neutral to Buy and set a new price target of $500.00
- SECHumana Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - HUMANA INC (0000049071) (Filer)
- PRHumana Elects Paul Smith and Frederick Crawford to Board of DirectorsSmith is the Chief Commercial Officer at Anthropic PBC and brings 30+ years scaling go-to-market strategies at the world's leading enterprise technology companies Crawford brings decades of experience as Chief Financial Officer of three publicly traded insurers, most recently serving as President and Chief Operating Officer of Aflac before his retirement Humana Inc. (NYSE:HUM) today announced that the Company’s Board of Directors has elected Paul Smith and Frederick Crawford as new Board members, effective immediately. Smith is the Chief Commercial Officer at Anthropic, PBC where he leads commercial strategy and global go-to-market operations as the company scales to meet growing e
- SECHumana Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits8-K - HUMANA INC (0000049071) (Filer)
- PRHumana Reports Second Quarter 2026 Financial Results; Affirms Full Year 2026 Adjusted Financial GuidanceReports 2Q26 earnings per share (EPS) of $5.73 on a GAAP basis, Adjusted EPS of $7.61; reports year to date (YTD) 2026 EPS of $15.55 on a GAAP basis, $17.91 on an Adjusted basis 2Q26 Insurance segment GAAP benefit ratio of 91.2 percent, in line with management's guidance of 'slightly above 91 percent'; affirms full year (FY) 2026 Insurance segment benefit ratio guidance of 92.75 percent, plus or minus 25 basis points Affirms FY 2026 Adjusted EPS guidance of 'at least $9.00'; while revising GAAP EPS guidance to 'at least $6.52' from the previous estimate of 'at least $8.36' Affirms FY 2026 individual Medicare Advantage (MA) membership growth of 'approximately 25 percent' over 2025;
- PRNew Humana Healthcare Research Study Finds Favorable Selection in Medicare Advantage is Substantially Lower Than MedPAC EstimatesPublished in Health Affairs Scholar, the study finds that a single methodological refinement reduces favorable selection estimates by 42%-65%, suggesting a smaller impact on MA payments than previous analyses have indicated A new study from Humana Healthcare Research (HHR), published in Health Affairs Scholar, finds that favorable selection in Medicare Advantage (MA) may be significantly lower than commonly cited estimates suggest. Favorable selection refers to the extent to which MA enrollees incur lower costs than predicted after risk adjustment and is an important factor in MA payment policy debates. The study found that a single methodological refinement substantially reduced favorabl
- ANALYSTHumana upgraded by Wells Fargo with a new price targetWells Fargo upgraded Humana from Equal Weight to Overweight and set a new price target of $502.00
- INSIDERSEC Form 4 filed by Director Hilzinger Kurt J4 - HUMANA INC (0000049071) (Issuer)
- PRThe Humana Foundation Deepens Investment in Emotional Health, Announcing Over $12 Million in New Grants2026 investments focus on scaling community-based programs and funding innovative research to end senior loneliness The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE:HUM) for the past 45 years, today announced its first slate of 2026 grants, dedicating over $12.2 million to programs and research focused on emotional well-being. The funding will support 13 nonprofit organizations and five university research teams focused on combating loneliness, depression and social isolation among seniors and veterans nationwide. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260630878218/en/Stronger connections lead to bette
- SECSEC Form 11-K filed by Humana Inc.11-K - HUMANA INC (0000049071) (Filer)
- SECSEC Form 11-K filed by Humana Inc.11-K - HUMANA INC (0000049071) (Filer)
- PRHumana Inc. to Release Second Quarter 2026 Results on July 29, 2026Humana Inc. (NYSE:HUM) will release its financial results for the second quarter 2026 (2Q26), as well as prepared management remarks (in PDF format), at 6:00 a.m. Eastern time on July 29, 2026. The company will host a live question-and-answer session at 8:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2026. A webcast of the 2Q26 earnings call may be accessed via Humana’s Investor Relations page at https://humana.gcs-web.com/. If you anticipate asking a question during the question-and-answer session, please register in advance using this link, https://register-conf.media-server.com/register/BI18085d824058461aa3c6b8b2af27cb40.
- PRHumana Awarded Statewide Illinois HealthChoice Medicaid Contract, Expanding Access to Care Across the StateHumana Inc. (NYSE:HUM) has been selected by the Illinois Department of Healthcare and Family Services (HFS) to serve members statewide in HealthChoice Illinois, the state's Medicaid managed care program. Humana looks forward to supporting Illinois' goals for health and well-being of the individuals and families it will serve. For more than a decade, Humana has had the privilege of serving some of Illinois' most vulnerable residents, caring for dual eligible members who navigate both Medicare and Medicaid through the Medicare-Medicaid Alignment Initiative (MMAI), and, today, the state's Fully Integrated Dual Eligible Special Needs Plan (FIDE-SNP) which launched January 1, 2026. HealthChoic
- PRHumana Announces Agreement to Divest Minority Interest in GentivaHumana Inc. (NYSE:HUM) today announced that it has signed a definitive agreement with a consortium of investors to divest all or substantially all of its minority interest in Gentiva, the nation's leading provider of end-of-life services, including hospice and palliative care. The agreement values Humana's minority interest stake at approximately $900 million. Other financial terms were not disclosed. Humana intends to utilize proceeds from the sale for general corporate purposes. The transaction is expected to close in the third quarter of 2026, subject to regulatory approvals and other customary closing conditions, and the company does not anticipate a material impact to 2026 earnings fro
HUM FAQ
7 questionsWhat does Humana Inc. do?
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through Retail, Group and Specialty, and Healthcare Services segments. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured...Where does HUM stock trade?
Humana Inc. (HUM) is listed on NYSE.What sector and industry is HUM in?
Humana Inc. operates in the Health Care sector, Medical Specialities industry.Does HUM pay a dividend?
HUM's most recent ex-dividend date was 2026-06-26 with a cash dividend of $0.89 per share. No future ex-date is on file yet.What are analysts saying about HUM?
Humana Inc. has had 8 recent analyst actions on file. The most recent action was from Morgan Stanley: Equal-Weight on 2026-08-05.What companies are similar to HUM?
Notable peers in the same industry include UNH (UnitedHealth Group Incorporated), ANTM (Anthem Inc.), ELV (Elevance Health Inc.), CI (The Cigna Group), NTRA (Natera Inc.). Compare HUM side-by-side with any of them on Quantisnow.How can I track HUM on Quantisnow?
Quantisnow aggregates Humana Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow HUM to receive live email and push alerts on every new disclosure.